GHA unveils cutting-edge MALDI-TOF machine
The GHA laboratory has introduced a state-of-the-art MALDI-TOF mass spectrometer, which will benefit vulnerable cancer patients by enabling earlier and more precise treatment. The GHA has received funding from Prostate Cancer Support Gibraltar and the Kusuma Trust to acquire the mass spectrometer. The MALDI-TOF (Matrix-Assisted Laser Desorption Ionization Time of Flight) mass spectrometer is cutting-edge...
Continue Reading
Register free to get 10 premium articles/month.
Register NowSubscribe to get unlimited access
Subscribe NowAlready a subscriber? Login here